27Dec 2022
Effect of Ivermectin 600 μg/kg for 6 days vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial

Effect of Ivermectin 600 μg/kg for 6 days vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial

To evaluate the effectiveness of ivermectin, dosed at 600 μg/kg daily for six days compared with a placebo for the treatment of early mild to moderate COVID-19. Among outpatients with mild to moderate COVID-19, treatment with ivermectin, with a maximum targeted dose of 600 μg/kg daily for six days, compared with placebo, did not improve time to recovery. Therefore, these findings do not support using ivermectin in patients with mild to moderate COVID-19.

  • #family health

Like

Save

Share